Hospital Admissions due to Medication‐Related Harm in the Last 5 Years of Life: A Cohort Study
Australasian Journal on Ageing · 2025
DOI: 10.1111/ajag.70104 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Australasian Journal on Ageing, 2025. Verfasst von Judy R Mullan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Patient Admission, Hospitalization. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
Introduction
The World Health Organization (WHO) launched the third Global Patient Safety Challenge: Medication without Harm in 2017, aiming to reduce avoidable medication‐related harm. Recognising that medication‐related harm (MRH) accounts for the highest proportion of preventable harm, this initiative remains active and evolving. This study investigates the demographic and clinical factors associated with medication‐related hospital admissions among a cohort of decedents.
Methods
A retrospective cohort study was conducted using routinely collected non‐identifiable linked data from an Australian Local Health District (LHD). The study population comprised residents aged 65 years and over who died in one of the LHD hospitals between 2017 and 2019. Logistic regression models were used to estimate unadjusted and fully adjusted odds ratios for medication‐related hospital admissions.
Results
Among the 4353 decedents, 31%–40% experienced at least one hospital admission due to MRH in the last 5 years of life, accounting for 5% of total admissions. Higher rates of medication‐related admissions were observed among individuals aged below 70 years, those residing in metropolitan areas and residential aged care facility residents. Comorbidities such as renal failure, heart failure, transient ischaemic attack, hypertension, diabetes and chronic obstructive pulmonary disease (COPD) were significant predictors of medication‐related admissions.
Conclusions
In our cohort of decedents, one‐third had at least one hospitalisation due to MRH in their final 5 years. Higher risk was associated with being under 70 years of age, living in metropolitan or aged care settings and having multiple or specific chronic conditions. These results highlight the need for targeted interventions for high‐risk individuals nearing the end of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia.
- Australasian Health Outcomes Centre, University of Wollongong, Wollongong, New South Wales, Australia.
ORCID-Profile: Judy R Mullan, Stephen Moules
Zitieren
APA
Mullan, J. R., Moules, S., & Bonney, A. (2025). Hospital Admissions due to Medication‐Related Harm in the Last 5 Years of Life: A Cohort Study. Australasian Journal on Ageing. https://doi.org/10.1111/ajag.70104
Vancouver
Mullan JR, Moules S, Bonney A. Hospital Admissions due to Medication‐Related Harm in the Last 5 Years of Life: A Cohort Study. Australasian Journal on Ageing. 2025. doi:10.1111/ajag.70104
BibTeX
@article{Mullan2025,
author = {Mullan, Judy R and Moules, Stephen and Bonney, Andrew},
title = {Hospital Admissions due to Medication‐Related Harm in the Last 5 Years of Life: A Cohort Study},
journal = {Australasian Journal on Ageing},
year = {2025},
doi = {10.1111/ajag.70104}
}
EUVIMED